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ABSTRACT* 
There is a need for tools to measure the information 
patients need in order for healthcare professionals 
in general, and particularly pharmacists, to 
communicate effectively and play an active part in 
the way patients manage their medicines. Previous 
research has developed and validated constructs to 
measure patients’ desires for information and their 
perceptions of how useful their medicines are. It is 
important to develop these tools for use in different 
settings and countries so that best practice is 
shared and is based on the best available evidence.  
Objectives: this project sought to validate of a 
survey tool measuring the “Extent of Information 
Desired” (EID), the “Perceived Utility of Medicines” 
(PUM), and the “Anxiety about Illness” (AI) that had 
been previously translated for use with Portuguese 
patients.  
Methods: The scales were validated in a patient 
sample of 596: construct validity was explored in 
Factor analysis (PCA) and internal consistency 
analysed using Cronbach’s alpha. Criterion validity 
was explored correlating scores to the AI scale and 
patients’ perceived health status. Discriminatory 
power was assessed using ANOVA. Temporal 
stability was explored in a sub-sample of patients 
who responded at two time points, using a T-test to 
compare their mean scores.   
Results: Construct validity results indicated the 
need to remove 1 item from the Perceived Harm of 
Medicines (PHM) and Perceived Benefit of 
Medicines (PBM) for use in a Portuguese sample 
and the abandon of the tolerance scale. The internal 
consistency was high for the EID, PBM and AI 
scales (alpha>0.600) and acceptable for the PHM 
scale (alpha=0.536). All scales, except the EID, 
were consistent over time (p>0.05; p<0.01). All the 
scales tested showed good discriminatory power. 
The comparison of the AI scale with the SF-36 
indicated good criterion validity (p<0.05). 
Conclusion: The translated tool was valid and 
reliable in Portuguese patients- excluding the 
Tolerance scale.  Some of the scales may benefit 
from further refinement, such as the PHM subscale. 
                                            
*Filipa Alves da COSTA. MSc, PhD. Auxiliary Professor, 
Instituto Superior de Ciências da Saúde, ISCSEM. 
Caparica (Portugal). 
Catherine DUGGAN, BPharm(Hons), PhD, MRPharmS. 
Senior Clinical Lecturer - School of Pharmacy, University 
of London, and Associate Director for Clinical Pharmacy, 
Development and Evaluation for East and South East 
England Specialist Services (NHS). London (United 
Kingdom). 
Ian BATES. BPharm, MSc, FRSH, MRPharmS. Professor 
and Head of Educational Development. School of 
Pharmacy, University of London. London (United 
Kingdom). 
Keywords: Cross-Cultural Comparison. Validation 
Studies as Topic. Portugal.  
 
 
VALIDACIÓN DE UN INSTRUMENTO DE 
ENCUESTA EN ESTUDIOS TRANS-
CULTURALES 
 
RESUMEN 
Se necesitan herramientas para medir la 
información que necesitan los pacientes para que 
los profesionales de la salud en general, y los 
farmacéuticos en particular, comuniquen 
efectivamente y jueguen un papel activo en como 
los pacientes manejan su medicación. Anteriores 
estudios han desarrollado instrumentos para medir 
los deseos de los pacientes de información y sus 
percepciones sobre la utilidad de los medicamentos. 
Es importante desarrollar estas herramientas en 
diferentes escenarios y países para compartir la 
mejor práctica y que se base en la evidencia 
disponible. 
Objetivos: Este proyecto trató validar una 
herramienta de encuesta que mide la “Cantidad de 
Información Deseada” (CID), la “Utilidad 
Percibida de la Medicación” (UPM), y la 
“Ansiedad sobre la Enfermedad” (AE) que fueron 
previamente traducidos para el uso con pacientes 
portugueses. 
Métodos: Las escalas se validaron en una muestra 
de 596 pacientes: la validez de constructo fue 
explorada en un análisis factorial y la consistencia 
interna se analizó usando un alfa de Cronbach. La 
validez de criterio se exploró correlacionando las 
puntuaciones a la escala AE y al estado de salud 
percibido de los pacientes. El poder discriminante 
se evaluó utilizando un ANOVA. La estabilidad 
temporal se exploró en una sub-muestra de 
pacientes que respondieron en dos momentos, 
usando un test-T para comparar sus puntuaciones 
medias. 
Resultados: La validez de constructo indicó la 
necesidad de retirar un ítem de Daño Percibido de 
los Medicamentos (DPM) y de Beneficio Percibido 
de los Medicamentos (BPM) para el uso en una 
muestra portuguesa y el abandono de la escala de 
tolerancia. La consistencia interna fue alta para las 
escalas CDI, UPM y AE (alfa>0,06) y aceptable 
para DPM (alfa=0,536). Todas las escalas, excepto 
CID fueron estables en el tiempo (p>0.05; p<0.01). 
Todas las escalas probadas mostraron alta 
capacidad discriminante. La comparación de la 
escala AE con el SF-36 indicó una buena validez de 
criterio (p<0,05). 
Conclusión: La herramienta traducida fue valida y 
fiable en pacientes portugueses, excluyendo la 
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escala de tolerancia. Algunas de las escalas pueden 
beneficiarse de un refinamiento posterior, como la 
sub-escala DPM. 
 
Palabras clave: Comparación trans-cultural. 
Estudios de validación como tema. Portugal. 
 
 
 
 
INTRODUCTION 
The development of standardised scales to assess 
the information each patient wants can be of major 
importance to effectively target health care 
interventions.  A survey tool has been developed to 
explore patients’ desires for information and their 
perceptions about prescribed therapy and illness. 
The initial tool, comprising 5 constructs, has been 
used in several studies and has been shown to 
describe and predict patients’ information needs 
and perceptions of their medicines. Further 
validation of three of these constructs has led to 
factors describing the “Intrinsic Desire for 
Information” (IDI), the “Perceived Utility of 
Medicines” (PUM), and the “Anxiety about Illness” 
(AI).2 Additional work on the initial 12-item IDI scale 
resulted in a 6-item scale: “Extent of Information 
Desired” (EID).1,3 
An important attribute when developing a practical 
scale is its length; this scale uses the minimum 
number of items comprising three important 
dimensions: the way the individual perceives his 
illness; the way he perceives his medicines; and 
takes into account the importance of patient-health 
care professional communication. Considering the 
potential utility of such tools for health-care 
professionals to increase their awareness of 
patients’ desires, perceptions and feelings, the 
applicability of such a scale in other countries and 
settings was evaluated.   
There is a problem when directly applying scales 
developed in English speaking countries for use in 
non-English speaking countries (eg: English scales 
for use in Portugal) and will increase as more 
countries enter the European Union. Networks to 
foster collaborative work are established across 
Europe to share and compare data.4 It is therefore 
important to adapt scales in a robust way for use 
across cultures that can assist health care 
professionals to target interventions to improve 
patient care.  
The aim of this study was to validate a survey tool 
to measure patients’ information desires and 
perceptions about medicines and illness in a 
Portuguese patient sample. 
 
METHODS  
Ethics  
Ethical approval had previously been obtained for 
the UK data. In Portugal, no official ethics approval 
systems were in place applicable to this study 
design and content, so a written authorisation was 
obtained from the head of each service or hospital, 
accordingly. 
Study design 
An initial exploratory study using a cross-sectional 
design evaluated two subsequent versions of the 
translated tool in regards to validity and internal 
consistency. The tool’s consistency was tested over 
time through a test-retest longitudinal study.  
Sample 
Previous research showed that 5 factors emerged 
from the pool of 50 items.  The sample size was 
calculated to be 250 recruits for validation purposes 
and another 200 for purposes of test-retest reliability 
analysis. The latter sample would detect differences 
between mean scores to the scales for a 95% 
confidence interval (5% error and an 80% power). 
This paper describes part of a larger study but all 
data collected by the time of submission is 
presented.  
A pilot study was undertaken in GEM patients to 
ensure that data collection materials and methods 
were appropriate for the main study. The main study 
involved testing the final version in an independent 
medical patient sample. The inclusion criteria 
restricted participants to adult patients prescribed 
with medication, understanding written and/or 
spoken Portuguese and agreeing to participate in 
the study once informed. Patients were invited to 
participate and were then provided with additional 
information about the research by means of a 
written invitation. Prior to the interview, patients 
read and signed an informed consent form.  
Participants recruited in the hospital setting were 
interviewed at their bedside using a standardised 
questionnaire, comprising three main sections: 
demographic data, diagnoses and prescribed 
medicines; the survey tool’s items, which were 
statements to be answered using a 5-point Likert 
scale, ranging from strongly agree to strongly 
disagree; and a set of open questions to address 
the concepts explored through the scales. In the 
community pharmacy setting, questionnaires were 
self-administered while similar in content. Patients 
who were unwilling to participate were given a 
refusal form, seeking to explore different 
characteristics of non-respondents.  
Data analysis 
Data were analysed using descriptive statistics to 
characterise the sample and responses to the 
scales. The Kolmogorov-Smirnov Test was used to 
explore the distribution of scores to scales before 
deciding on the use of parametric or non-parametric 
tests. Construct validity was explored in factor 
analysis, using Principal Components Analysis 
(PCA) with Oblimin rotation. The emerging 
subscales were subsequently compared with 
retrospective UK data. Criterion validity was 
explored by correlating scores to the anxiety scale 
and patients’ responses to the SF-36 general 
question included in the questionnaire using 
Spearman’s rho. The tool’s discriminatory power 
was assessed using ANOVA or independent 
samples t-test, as appropriate. Internal consistency 
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was analysed using Cronbach’s coefficient alpha 
and inter-item correlations (r) and again compared 
with the UK retrospective data. Test-retest reliability 
was explored in a sub-sample of patients who 
responded to the questionnaire at two time points 
one month apart. Data were treated as paired 
samples, using a t-test to compare their mean 
scores. 
 
RESULTS  
A sample of 62 patients was recruited for the pilot 
phase. This highlighted difficulties in recruitment 
associated with some of the study sites where 
access was restricted to acute care wards. 
Therefore, inclusion criteria were reviewed to widen 
the recruitment possibilities.   
Table 1 summarises the demographic, medical and 
therapeutic characteristics of the 596 cases 
included in the sample. Gender was evenly 
distributed; the mean age was as expected given 
the focus on chronically ill patients. There was a 
high proportion of people without education and an 
extremely high proportion of individuals with primary 
school education. Cardiovascular and endocrine 
patients (57%) were the most common diagnoses.  
The number of non-respondents was very low 
(n=25; 4%), hence no statistical tests were 
performed to evaluate differences between the two 
samples.  
 
Table 1 – Portuguese sample characteristics 
Characteristic Variables n % 
Male 249 42 Gender (n=596) 
Female 347 58 
No education (illiterate)  36 6 
No education (literate) 50 9 
Primary school 248 43 
Preparatory school 25 4 
Secondary school 95 17 
High school 51 9 
Educational level  
(n=575; 21 missing) 
University (including post-graduate) 70 12 
Cardiovascular System (e.g. hypertension, angina) 190 32 
Endocrine System (e.g. diabetes, thyroid disorders) 148 25 
Respiratory System (e.g. asthma, COPD) 65 11 
CNS (e.g. depression, Alzheimer) 67 11 
GI System (e.g. peptic ulcer, gastritis) 33 6 
Immune System (e.g. lupus; rheumatoid arthritis) 24 4 
Tumours (e.g. lung cancer, stomach cancer)  11 2 
Existing condition 
(n=596) 
Other (includes Musculoskeletal System, Renal or Hepatic System, 
Sensorial organs, Blood disorders, Transplants, Genital disorders, 
Intoxication and unspecific symptoms) 
58 10 
Characteristic  Mean; median; sd 
Age (n=595; 1 missing) 59.0; 62.0; 15.1 
Rx medicines (n=589; 7 missing) 4.4; 4.0; 2.8 
Note: n differs between variables because of missing data 
 
Validity of the scales 
Criterion validity was judged to be good. A negative 
and statistically significant correlation was found 
when comparing the AI scale with the external 
measure (rho=-0.318; p<0.001), indicating that 
patients who perceived their health status as worse 
were more anxious.   
Construct validity: Principal components analysis 
resulted in 6 factors, rather than the predicted 5 
(table 2). Factor 6, when compared to the original 
tool, was judged to be the combination of those 
items that did not “work” in a Portuguese sample, 
despite modifications during translation. This factor 
comprised the items A4 (I just want to blame 
someone for the way I feel) and T1 (I find my 
medicines easy to take, I am used to them).  
Most items fell into the expected domains for the AI 
and EID scales. The Tolerance scale (Ti), a 
subscale of the “Anxiety about Illness” scale 
originally had weak internal consistency 
(alpha=0.470) and contained only 3 items; one of 
which did not load into this factor and was then 
dropped, leaving this scale with only two items, 
insufficient to form a scale. As such, the Ti scale 
was dropped and considered unsuitable for the 
Portuguese population.   
The items of the PUM scale loaded well into the 
expected sub-factors. The exception was the 
previously described item T1 and was dropped. 
Both the PHM and PBM subscales comprised only 
3 items, rather than the UK sample 4.  The version 
to be used in Portugal had therefore the tolerance 
scale removed as well as one item of the PUM 
scale. The final scale comprised a total of 16 items. 
Reliability of the scales 
Both the EID and PHM scales showed acceptable 
internal consistency (alpha=0.607 and 0.536, 
respectively), which could be further improved by 
additional modifications. The AI and the PBM scales 
revealed good internal consistency estimates 
(alpha=0.695 and 0.756, respectively). In all scales, 
the removal of any item would result in a decrease 
of its overall internal consistency. Table 3 displays 
the Cronbach’s alpha values and the inter-item 
correlations range for each scale and item in the 
Portuguese sample and their comparison with 
retrospective UK data.  
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Table 2 - Structure Matrix of the constructs emerging from the translated tool. 
 AI Ti PBM PHM EID F6 
I get really worried about it all, the worry makes 
me ill 
0.814      
I can’t get used to this illness, I just get worried 
about it 
0.783      
I feel anxious and concerned about the future 0.745      
I can’t accept that there is something wrong, 
why me? 
0.635      
I feel fine about my illness, you can’t expect to 
always be well 
 -0.759     
I would like to be completely better, but a bit 
better is good enough 
 -0.637     
I find my medicines easy to take, I am used to 
them  
 -0.512    0.450 
I just want to blame someone for the way I feel      0.751 
I trust my medicines will make me better   0.794    
My medicines relieve my symptoms   0.792    
Without my medicines I would be so much 
worse 
  0.634    
The side effects are another form of disease    0.753   
I feel “trapped” by my medicines, I have to take 
them 
   0.730   
It’s hard to take my medicines, because taking 
them has altered my lifestyle 
   0.443   
I don't need any more knowledge      0.759  
What you don't know doesn't hurt you      0.665  
Too much knowledge is a bad thing      0.659  
You can never know enough about these things     -0.430  
I need as much information about my 
medicines as possible 
    -0.408  
I read about my medicines / illness as much as 
possible 
    -0.339  
 
Table 3 - Internal consistency of the 4 subscales in the Portuguese sample, compared with the original English version. 
 Mean if 
item 
deleted 
Variance if 
item 
deleted 
r Multiple 
r2 
α if item 
deleted 
EID Portuguese version alpha=0.607; EID original alpha =0.784 
I need as much information about my medicines as 
possible 
18.3 16.525 0.355 0.198 0.563 
You can never know enough about these things 18.3 17.334 0.276 0.130 0.588 
I read about my medicines / illness as much as 
possible 
18.9 15.317 0.303 0.158 0.579 
Too much knowledge is a bad thing (recoded) 19.1 14.660 0.340 0.178 0.564 
I don't need any more knowledge (recoded) 18.9 13.651 0.439 0.216 0.517 
What you don't know doesn't hurt you (recoded) 19.2 14.554 0.351 0.173 0.559 
PBM Portuguese version alpha=0.695; PBM original=0.784 
My medicines relieve my symptoms 8.9 1.732 0.573 0.337 0.518 
I trust my medicines will make me better 8.8 1.863 0.539 0.308 0.566 
Without my medicines I would be so much worse 8.6 2.329 0.432 0.188 0.696 
PHM Portuguese version alpha=0.536; PHM original=0.746 
I feel 'trapped' by my medicines, I have to take them 5.4 4.564 0.395 0.157 0.353 
It's hard to take my medicines, because taking them 
has altered my lifestyle 
6.4 5.586 0.313 0.101 0.488 
The side-effects are another form of disease 5.6 5.241 0.339 0.121 0.449 
AI Portuguese version alpha=0.756; AI original=0.740 
I can't get used to this illness, I just get worried about 
it 
9.1 11.732 0.549 0.306 0.700 
I get really worried about it all, the worry makes me ill 9.2 11.031 0.629 0.400 0.654 
I feel anxious and concerned about the future 8.7 11.958 0.550 0.319 0.700 
I can't accept that there is something wrong, why 
me? 
9.6 12.711 0.483 0.237 0.734 
 
 
All scales, except the EID were consistent over 
time, since their mean scores did not differ between 
baseline and after one month. The correlation 
between the PBM, PHM, and AI scores (at baseline 
and after one month) was high and statistically 
significant, indicating the concepts are being 
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measured consistently. Furthermore, their mean 
scores were not significantly different, confirming 
these scales are consistent over time. Scores to the 
EID scale were strongly correlated between the two 
time points, but mean scores were significantly 
higher at baseline (25.9) than after one month 
(24.2) which implies patients seem to want less 
information as time goes on- maybe they are more 
“used” to their medicines by this stage 
Discriminatory power  
The scores to the four valid scales were explored in 
samples of inpatients, outpatients and community 
pharmacy patients. Significant differences between 
mean scores to scales were detected for the EID 
scale between patients in the three settings 
(F=9.891; p<0.001) and the AI scale (F=4.916; 
p=0.008). This implies patients recruited from 
different study sites had different desires for 
information and levels of anxiety about their illness.  
To ensure that the setting had no further influence 
on the scales’ discriminatory power, analysis was 
restricted to community pharmacy patients. 
Females scored significantly higher than males to 
the PBM scale (t=-2.174; p=0.031). Age was 
negatively correlated with scores to the EID scale 
(r=-0.24; p<0.001) and positively correlated with 
scores to the AI scale (r=0.16; p=0.001), both 
correlations weak but statistically significant. 
Categorizing age into two broad groups additionally 
showed that younger patients expressed a higher 
desire for information (t=4.19; p<0.001) and lower 
anxiety about their illness (t=-2.00; p=0.047).  
The mean scores to the EID, PHM and the AI 
scales varied significantly between the lowest 
educational level and all others (EID: F=3.92; 
p<0.001); (PHM: F=2.10; p=0.011); (AI: F=5.18; 
p<0.001). The desire for information increased, the 
perception of harm and anxiety decreased as years 
of formal education increased. Patients prescribed 5 
or more drugs scored significantly higher on the 
Anxiety scale (t=-3.22; p=0.001). It may be 
assumed that when patients are prescribed more 
drugs, they interpret this as a signal of deterioration 
in their condition, hence increasing their anxiety.   
In summary, the translated survey tool was found to 
be both valid and reliable after being tested in a 
patient sample of 596 patients with a wide 
representation of demographic and medical 
characteristics. The sample reflected the general 
characteristics of the Portuguese population well.   
The five scales described in the original UK 
research behaved differently in the Portuguese 
population following translation. The tolerance scale 
was dropped during the course of validation work as 
it was deemed to be unsuitable for use in this 
patient sample. Additionally, the two subscales in 
the PUM scale were transformed by dropping one 
common item as it did not load into any of the 
expected factors and internal consistency of both 
scales increased when it was deleted. Both the EID 
and the AI scales were left unaltered and found to 
have good construct validity. 
• The EID scale showed to have an acceptable 
internal consistency (alpha=0.607) but not being 
consistent over time (p<0.05; p<0.01). The EID 
scale was able to discriminate between settings, 
age group and educational levels (p<0.05). 
• The PBM scale showed to have a good internal 
consistency (alpha=0.695) and being consistent 
over time (p>0.05; p<0.01). Construct validity 
results led to dropping one of the items, whilst 
not compromising its reliability. This scale 
showed to discriminate between different 
genders (p<0.05). The distribution of scores to 
the PBM scale showed small spread, indicating 
a possibility for little added-value in its use.  
• The PHM scale was the one with the lowest 
internal consistency (alpha=0.536), considered 
fair, but being consistent over time (p>0.05; 
p<0.01). Construct validity results led to 
dropping one of the items, whilst not 
compromising its reliability. This scale showed to 
discriminate between educational levels 
(p<0.05).  
• The AI scale was the one with the highest 
internal consistency (alpha=0.756), considered 
good, and also showing consistency over time 
(p>0.05; p<0.01). This scale showed good 
results in regards to criterion validity, when 
compared with the SF-36 (p<0.05). Additionally 
it showed to discriminate between settings, age 
group, educational levels and number of 
prescribed drugs (p<0.05). 
 
DISCUSSION 
The characteristics of the sample were compared to 
national data, where illiterate people represent 8% 
of the population (compared to 7% in the study 
sample) and people with university education 
account for 11% (compared to 12% in this sample). 
Study recruits with primary school education 
accounted for 47% of the sample, compared to 35% 
in the national population. Nonetheless, it may be 
concluded that the sample educational level 
represents the Portuguese population fairly well.5 
Internal consistency of the EID was not as high as 
expected from previous UK studies.1-3 A Cronbach’s 
alpha value of 0.7 has been suggested as good6 
and the fact that the value reported for the EID in 
the Portuguese sample roughly passes 0.6 is an 
issue of concern. However, this scale has been 
further tested in another study including 112 
hypertensive patients recruited from Lisbon 
pharmacies, where the value obtained was 0.683.7 
This increase may be related to distinct 
characteristics of the samples, the latter study was 
conducted in a particularly developed area, where 
educational levels are generally higher. This may 
imply that this scale’s performance may improve as 
the Portuguese population’s literacy increases. This 
trend is supported by successive legislation 
reviewing the minimum compulsory education.8  
Consistency over time for the EID scale was not 
detected which may be due to the changes made 
just by asking the patients; and possible 
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interventions made by the pharmacists while 
administering the questionnaire, simply by being 
aware of patients’ desires. Alternatively, information 
needs may be easily changed dependent on 
situations, time, severity of symptoms, whereas 
anxiety and perceptions of medicines may be less 
so.  
Face and content validity have also been examined, 
albeit reported elsewhere9, where problems were 
revealed for the EID, PHM and Ti scales. The latter 
was dropped; the others may need additional work 
when being tested in practice. Additional problems 
were encountered with the Anxiety scale as it led to 
anguish in some patients, which could potentially 
compromise its use in pharmacy practice. 
Nonetheless, it may be worth exploring its 
applicability in medical settings, where scales such 
as the Beck’s Depression Inventory (BDI) have 
been employed.10  
Criterion validity is often not reported due to lack of 
comparable measures in this area (which further 
validates the need to develop them). In this study, 
criterion validity was explored in three different 
ways, using qualitative data, interfacing qualitative 
and quantitative data and external measures to 
correlate with some of the scores to scales, 
although only the latter was expanded in this 
manuscript. Other external measures could have 
been used for comparison with the PUM scale, such 
as the BMQ.11 This would have undisputed 
advantages, but also an additional burden for 
respondents which could potentially have an impact 
on the response rate, so was disregarded in this 
study. Additionally, this questionnaire is not 
validated to Portuguese. There is no tool 
comparable to the EID that could have been used, 
leaving patients’ own words as the only possible 
option.  
Some of the limitations of this study include not 
having used an external measure for each scale to 
explore criterion validity, limiting quantitative 
analysis of this type of validity to the Anxiety scale. 
The limited length of hospital stay resulted in the 
impossibility of having repeated the questionnaire 
also in hospital patients to explore consistency over 
time, which would have the advantage of ensuring 
the same interviewer, minimising probabilities of 
interviewer-related bias.  
Selection bias in community pharmacy occurred 
since participating pharmacists had to combine 
participating in a research study with minimal impact 
on normal service delivery. The inability to 
guarantee response of refusal forms limited the 
usefulness of the analysis undertaken to explore 
comparability of respondent and non-respondents, 
but this was a limitation impossible to overcome as 
people cannot be forced to answer.   
 
CONCLUSIONS 
The main conclusions are that the translated tool 
was valid and reliable in Portuguese patients- 
excluding the Tolerance scale.  Some of the scales 
may benefit from further refinement, such as the 
PHM subscale. Successive modifications are 
needed to increase the tool’s validity and reliability 
and confirm that scales are not directly transferable 
from one country to another. This study 
demonstrates the importance of robust translation 
and validation processes to measure the concepts 
of interest in a credible manner. 
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